Hoffman R, Nimer A, Lanir N, Brenner B, Baruch Y
Department of Hematology, Rambam Medical Center, Haifa, Isreal.
Liver Transpl Surg. 1999 Mar;5(2):96-100. doi: 10.1002/lt.500050211.
Budd-Chiari syndrome is characterized by hepatic venous outflow obstruction. Although myeloproliferative disorders are usually responsible for this severe thrombotic disorder, deficiency or dysfunction of the natural anticoagulants can be involved. Resistance to activated protein C caused by factor V Leiden mutation has been recently identified as a major cause of thrombophilia. We report 6 patients with Budd-Chiari syndrome associated with factor V Leiden mutation combined with another acquired thrombophilic state (myeloproliferative disorder and lupus anticoagulant in 3 cases) and without another thrombophilic disorder in the other 3 cases. We conclude that factor V Leiden mutation should be evaluated in any case of hepatic vein occlusion because the prevalence of this mutation in the general population is high.
布加综合征的特征是肝静脉流出道梗阻。虽然骨髓增殖性疾病通常是这种严重血栓形成疾病的病因,但天然抗凝剂的缺乏或功能障碍也可能与之相关。由因子V莱顿突变引起的活化蛋白C抵抗最近被确定为血栓形成倾向的主要原因。我们报告了6例布加综合征患者,他们伴有因子V莱顿突变,并合并另一种获得性血栓形成倾向状态(3例为骨髓增殖性疾病和狼疮抗凝物),另外3例无其他血栓形成倾向疾病。我们得出结论,在任何肝静脉闭塞病例中都应评估因子V莱顿突变,因为该突变在普通人群中的患病率很高。